Related Experiment Videos
Immune dysfunction in patients with diabetes mellitus (DM)
1Department of Medicine, Division Infectious Diseases and AIDS and Eijkman-Winkler Laboratory for Medical Microbiology, University Hospital Utrecht, The Netherlands. s.e.geerlings@digd.azu.nl
FEMS Immunology and Medical Microbiology
|November 27, 1999
Summary
Patients with diabetes mellitus (DM) experience more frequent and severe infections due to immune system defects. Improved blood sugar control can enhance immune cell function, potentially reducing infection risk.
Area of Science:
- Immunology
- Endocrinology
- Infectious Diseases
Background:
- Diabetes mellitus (DM) is associated with increased infection incidence and severity.
- Immune system dysfunction is a suspected cause of heightened infection susceptibility in diabetic patients.
- While adaptive immunity appears largely unaffected, innate immunity shows disturbances in DM.
Purpose of the Study:
- To investigate the impact of diabetes mellitus on immune function and infection susceptibility.
- To explore the mechanisms underlying increased infection risk in diabetic individuals.
- To assess the role of innate immunity defects in diabetic patients' infections.
Main Methods:
- Review of existing literature on immune responses in patients with diabetes mellitus.
- Analysis of studies examining cellular and humoral innate immunity in diabetic versus non-diabetic individuals.
- Investigation of microbial virulence and adherence in high-glucose environments.
Main Results:
- Diabetic patients exhibit impaired functions of polymorphonuclear cells, monocytes, and macrophages.
- Humoral innate immunity shows disturbances, including low complement factor 4 and altered cytokine responses.
- Some microorganisms exhibit increased virulence and adherence to cells in high-glucose conditions.
- Better glycemic control in DM correlates with improved immune cell function.
Conclusions:
- Defects in cellular innate immunity are prevalent in patients with diabetes mellitus.
- These immune deficits, coupled with enhanced microbial virulence and adherence, contribute to increased infection risk.
- Therapeutic strategies aimed at improving glycemic control may help mitigate infection susceptibility in diabetic patients.